%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Johannes Ettl, Evelyn Klein, Alexander Hapfelmeier, Kirsten Grosse Lackmann, Stefan Paepke, Christoph Petry, Katja Specht, Laura Wolff, Heinz Höfler, Marion Kiechle
Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 12 0 R/Contents 13 0 R/TrimBox[0 0 612 792]>>
endobj
12 0 obj
[14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R]
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref001)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref002)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref003)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref004)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref005)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref006)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref007)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref008)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref009)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref010)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0183917.ref011)>>
endobj
25 0 obj
<>/Border[0 0 0]/A 26 0 R>>
endobj
26 0 obj
<>
endobj
13 0 obj
[27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R]
endobj
27 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 580.6142 m
199.9998 580.6142 l
199.9998 581.1143 l
575.9997 581.1143 l
f*
0.83 0.64 0.02 0 k
544.8189 484.8945 m
549.5811 484.8945 l
h
f*
233.178 458.9291 m
237.9402 458.9291 l
h
f*
352.7433 341.915 m
357.5055 341.915 l
h
f*
557.5181 328.9323 m
562.2803 328.9323 l
h
f*
473.7827 302.9102 m
478.4882 302.9102 l
h
f*
563.7543 289.9276 m
568.5165 289.9276 l
h
f*
376.3276 224.9008 m
381.0898 224.9008 l
h
f*
405.9213 198.9354 m
410.6835 198.9354 l
h
f*
385.3417 172.9134 m
390.1039 172.9134 l
h
f*
468.3969 133.9087 m
477.9213 133.9087 l
h
f*
486.9354 133.9087 m
496.4031 133.9087 l
h
f*
0 g
1 j
1 J
9.5 0 0 9.5 200.0125 707.7543 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(results.)Tj
3.4075 0 Td
(EPclin)Tj
3.0256 0 Td
(resulted)Tj
3.7298 0 Td
(more)Tj
2.4765 0 Td
(frequently)Tj
4.5593 0 Td
(in)Tj
0.9847 0 Td
(a)Tj
0.7698 0 Td
(change)Tj
3.4613 0 Td
(of)Tj
1.0443 0 Td
(therapy)Tj
3.5209 0 Td
(recommendation)Tj
7.5849 0 Td
(than)Tj
2.1484 0 Td
(the)Tj
-36.713 -1.474 Td
(uPA/PAI-1)Tj
4.8517 0 Td
(test)Tj
1.8261 0 Td
(\(46%)Tj
2.5243 0 Td
(vs)Tj
1.2174 0 Td
(24%\).)Tj
2.8048 0 Td
(Recommendat)Tj
6.445 0 Td
(ion)Tj
1.5278 0 Td
(of)Tj
1.0503 0 Td
(adjuvant)Tj
3.9506 0 Td
(chemotherapy)Tj
6.4928 0 Td
(\(CTX\))Tj
2.8704 0 Td
(was)Tj
-35.5612 -1.474 Td
(abandoned)Tj
5.156 0 Td
(twice)Tj
2.4766 0 Td
(as)Tj
1.2651 0 Td
(often)Tj
2.4169 0 Td
(by)Tj
1.2652 0 Td
(EPclin)Tj
3.0256 0 Td
(\(45%\))Tj
2.8585 0 Td
(compared)Tj
4.6189 0 Td
(to)Tj
1.0444 0 Td
(uPA/PAI-1)Tj
4.8577 0 Td
(\(22%\).)Tj
ET
Q
q
1 j
1 J
0 w
11.4998 0 0 11.4998 200.0125 653.1023 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 636.0944 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(In)Tj
1.0443 0 Td
(this)Tj
1.7604 0 Td
(first)Tj
1.8142 0 Td
(prospective)Tj
5.2754 0 Td
(comparison)Tj
5.3291 0 Td
(of)Tj
1.0503 0 Td
(EPclin)Tj
3.0197 0 Td
(and)Tj
1.8679 0 Td
(uPA/PAI-1)Tj
4.8517 0 Td
(we)Tj
1.4859 0 Td
(found,)Tj
2.9719 0 Td
(that)Tj
1.8738 0 Td
(EPclin)Tj
3.0197 0 Td
(is)Tj
0.9309 0 Td
(supe-)Tj
-36.2952 -1.474 Td
(rior)Tj
1.6411 0 Td
(to)Tj
1.0443 0 Td
(uPA/PAI-1)Tj
4.8577 0 Td
(with)Tj
1.9753 0 Td
(respect)Tj
3.4672 0 Td
(to)Tj
1.0443 0 Td
(feasibility)Tj
4.2788 0 Td
(and)Tj
1.8619 0 Td
(decision)Tj
3.8372 0 Td
(impact.)Tj
3.4195 0 Td
(This)Tj
2.0887 0 Td
(leads)Tj
2.578 0 Td
(to)Tj
1.0443 0 Td
(substantial)Tj
-33.1383 -1.474 Td
(avoidance)Tj
4.7204 0 Td
(of)Tj
1.0443 0 Td
(adjuvant)Tj
3.9506 0 Td
(CTX)Tj
2.214 0 Td
(in)Tj
0.9847 0 Td
(endocrine-sensitive,)Tj
8.9992 0 Td
(HER2-negative)Tj
6.9284 0 Td
(breast)Tj
2.9719 0 Td
(cancer.)Tj
3.4613 0 Td
(Data)Tj
2.3154 0 Td
(col-)Tj
-37.5902 -1.468 Td
(lection)Tj
3.0673 0 Td
(for)Tj
1.3786 0 Td
(patients)Tj
4.0102 0 Td
(clinical)Tj
3.1688 0 Td
(outcome)Tj
4.0222 0 Td
(is)Tj
0.931 0 Td
(ongoing.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 529.0015 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 511.9937 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Patients)Tj
3.4072 0 Td
(diagnosed)Tj
4.2803 0 Td
(with)Tj
2.0012 0 Td
(early)Tj
2.1487 0 Td
(breast)Tj
2.6135 0 Td
(cancer)Tj
2.8459 0 Td
(are)Tj
1.4514 0 Td
(faced)Tj
2.313 0 Td
(with)Tj
1.9956 0 Td
(life-long)Tj
3.566 0 Td
(risk)Tj
1.7121 0 Td
(of)Tj
1.0148 0 Td
(distant)Tj
2.9593 0 Td
(metastases.)Tj
-32.309 -1.2982 Td
(Nevertheless,)Tj
5.4935 0 Td
(along)Tj
2.4207 0 Td
(with)Tj
1.9956 0 Td
(intensified)Tj
4.439 0 Td
(early)Tj
2.1487 0 Td
(detection)Tj
3.9344 0 Td
(and)Tj
1.7292 0 Td
(optimized)Tj
4.2576 0 Td
(adjuvant)Tj
3.702 0 Td
(systemic)Tj
3.6227 0 Td
(therapies,)Tj
-33.7434 -1.3039 Td
(an)Tj
1.2018 0 Td
(improvement)Tj
5.6693 0 Td
(of)Tj
1.0148 0 Td
(disease-free)Tj
4.8755 0 Td
(and)Tj
1.7292 0 Td
(overall)Tj
2.9026 0 Td
(survival)Tj
3.3392 0 Td
(could)Tj
2.4491 0 Td
(be)Tj
1.1509 0 Td
(observed)Tj
3.7984 0 Td
(in)Tj
1.0318 0 Td
(recent)Tj
2.7099 0 Td
(years)Tj
2.2677 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5987 0 Td
(In)Tj
-35.7389 -1.2983 Td
(the)Tj
1.4683 0 Td
(overall)Tj
2.9026 0 Td
(patient)Tj
3.0048 0 Td
(population,)Tj
4.8188 0 Td
(adjuvant)Tj
3.702 0 Td
(chemotherapy)Tj
5.9471 0 Td
(\(CTX\))Tj
2.829 0 Td
(shows)Tj
2.6588 0 Td
(a)Tj
0.6577 0 Td
(significant)Tj
4.388 0 Td
(therapeutic)Tj
-32.3771 -1.2983 Td
(benefit)Tj
2.9763 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.5987 0 Td
(However,)Tj
4.0762 0 Td
(focusing)Tj
3.6113 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.4684 0 Td
(population)Tj
4.5921 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(hormone)Tj
3.9231 0 Td
(receptor)Tj
3.5546 0 Td
(\(HR\))Tj
2.2904 0 Td
(pos-)Tj
-35.7446 -1.2982 Td
(itive)Tj
1.9275 0 Td
(disease,)Tj
3.2428 0 Td
(it)Tj
0.788 0 Td
(becomes)Tj
3.6851 0 Td
(clear)Tj
2.1203 0 Td
(that)Tj
1.7744 0 Td
(there)Tj
2.2677 0 Td
(are)Tj
1.4457 0 Td
(patient)Tj
3.0104 0 Td
(subgroups)Tj
4.3653 0 Td
(that)Tj
1.7745 0 Td
(will)Tj
1.6667 0 Td
(be)Tj
1.1509 0 Td
(cured)Tj
2.4945 0 Td
(just)Tj
1.6611 0 Td
(by)Tj
1.1792 0 Td
(adju-)Tj
-34.5541 -1.3039 Td
(vant)Tj
1.9558 0 Td
(endocrine)Tj
4.2577 0 Td
(therapy)Tj
3.2484 0 Td
(without)Tj
3.3279 0 Td
(adjuvant)Tj
3.702 0 Td
(CTX.)Tj
2.3754 0 Td
(Validated)Tj
4.0706 0 Td
(prognostic)Tj
4.49 0 Td
(markers)Tj
3.4979 0 Td
(are)Tj
1.4457 0 Td
(required)Tj
3.6397 0 Td
(to)Tj
-36.0111 -1.2983 Td
(identify)Tj
3.2938 0 Td
(this)Tj
1.6724 0 Td
(subgroup.)Tj
4.2293 0 Td
(Recognized)Tj
4.8415 0 Td
(conventional)Tj
5.4255 0 Td
(prognostic)Tj
4.4901 0 Td
(markers)Tj
3.4979 0 Td
(with)Tj
1.9956 0 Td
(proven)Tj
3.0444 0 Td
(relevance)Tj
-32.4905 -1.2983 Td
(are)Tj
1.4456 0 Td
(tumor)Tj
2.7439 0 Td
(size,)Tj
1.9106 0 Td
(nodal)Tj
2.4831 0 Td
(status,)Tj
2.7269 0 Td
(grading,)Tj
3.5263 0 Td
(histological)Tj
4.7678 0 Td
(subtype)Tj
3.3109 0 Td
(and)Tj
1.7291 0 Td
(age.)Tj
1.7688 0 Td
(Still,)Tj
1.9786 0 Td
(these)Tj
2.2563 0 Td
(biomarkers)Tj
4.7736 0 Td
(are)Tj
-35.4215 -1.3039 Td
(insufficient)Tj
4.7281 0 Td
(to)Tj
1.0261 0 Td
(obtain)Tj
2.778 0 Td
(adequate)Tj
3.7984 0 Td
(risk)Tj
1.7178 0 Td
(stratification)Tj
5.278 0 Td
(in)Tj
1.0375 0 Td
(a)Tj
0.652 0 Td
(HR-positive,)Tj
5.2837 0 Td
(HER2-negative)Tj
6.3212 0 Td
(population.)Tj
-32.6208 -1.2983 Td
(Therefore,)Tj
4.3936 0 Td
(a)Tj
0.652 0 Td
(number)Tj
3.4185 0 Td
(of)Tj
1.0148 0 Td
(additional)Tj
4.2747 0 Td
(new)Tj
1.8765 0 Td
(molecular)Tj
4.2179 0 Td
(biomarkers)Tj
4.7792 0 Td
(has)Tj
1.542 0 Td
(been)Tj
2.126 0 Td
(developed)Tj
4.269 0 Td
(and)Tj
1.7291 0 Td
(vali-)Tj
-34.2933 -1.2982 Td
(dated)Tj
2.4321 0 Td
(which)Tj
2.6475 0 Td
(allow)Tj
2.3357 0 Td
(a)Tj
0.6577 0 Td
(better)Tj
2.5398 0 Td
(defined)Tj
3.2258 0 Td
(distinction)Tj
4.5354 0 Td
(between)Tj
3.5263 0 Td
("high")Tj
2.6475 0 Td
(and)Tj
1.7291 0 Td
("low")Tj
2.2961 0 Td
(risk)Tj
1.7178 0 Td
(of)Tj
1.0148 0 Td
(metastases.)Tj
-30.1094 -1.3039 Td
(The)Tj
1.7858 0 Td
(urokinase)Tj
4.1555 0 Td
(plasminogen)Tj
5.3575 0 Td
(activator)Tj
3.7077 0 Td
(\(uPA\))Tj
2.6702 0 Td
(system)Tj
2.9423 0 Td
(plays)Tj
2.2337 0 Td
(an)Tj
1.2019 0 Td
(important)Tj
4.2803 0 Td
(role)Tj
1.7688 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(process)Tj
-33.8057 -1.2983 Td
(of)Tj
1.0147 0 Td
(tumor)Tj
2.744 0 Td
(cell)Tj
1.559 0 Td
(invasion)Tj
3.6057 0 Td
(and)Tj
1.7291 0 Td
(metastasis)Tj
4.2803 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
1.5987 0 Td
(As)Tj
1.2699 0 Td
(early)Tj
2.1487 0 Td
(as)Tj
1.0148 0 Td
(1988,)Tj
2.347 0 Td
(it)Tj
0.7824 0 Td
(was)Tj
1.7008 0 Td
(demonstrated)Tj
5.7599 0 Td
(that)Tj
1.7802 0 Td
(elevated)Tj
-33.3352 -1.2983 Td
(levels)Tj
2.3754 0 Td
(of)Tj
1.0148 0 Td
(uPA)Tj
1.9899 0 Td
(in)Tj
1.0374 0 Td
(tumor)Tj
2.744 0 Td
(tissue)Tj
2.4548 0 Td
(of)Tj
1.0148 0 Td
(breast)Tj
2.6191 0 Td
(cancer)Tj
2.8403 0 Td
(patients)Tj
3.3676 0 Td
(are)Tj
1.4513 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(poor)Tj
2.1203 0 Td
(prognosis)Tj
4.1272 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(].)Tj
-35.4101 -1.2982 Td
(Shortly)Tj
3.101 0 Td
(after,)Tj
2.2564 0 Td
(it)Tj
0.788 0 Td
(was)Tj
1.7008 0 Td
(shown)Tj
2.846 0 Td
(for)Tj
1.3889 0 Td
(the)Tj
1.4684 0 Td
(first)Tj
1.8028 0 Td
(time)Tj
2.0296 0 Td
(that)Tj
1.7801 0 Td
(also)Tj
1.7688 0 Td
(high)Tj
2.007 0 Td
(concentrations)Tj
6.1794 0 Td
(of)Tj
1.0148 0 Td
(plasminogen)Tj
5.3575 0 Td
(acti-)Tj
-35.4895 -1.3039 Td
(vator)Tj
2.2847 0 Td
(inhibitor-1)Tj
4.6091 0 Td
(\(PAI-1\))Tj
3.3051 0 Td
(are)Tj
1.4514 0 Td
(associated)Tj
4.2576 0 Td
(with)Tj
1.9956 0 Td
(a)Tj
0.6519 0 Td
(worse)Tj
2.5682 0 Td
(clinical)Tj
3.0784 0 Td
(course)Tj
2.8346 0 Td
([)Tj
0.83 0.64 0.02 0 k
(5)Tj
0 g
(].)Tj
1.5988 0 Td
(Observations)Tj
5.4991 0 Td
(in)Tj
1.0375 0 Td
(vari-)Tj
-35.172 -1.2983 Td
(ous)Tj
1.6157 0 Td
(animal)Tj
2.9707 0 Td
(models)Tj
3.1011 0 Td
(showed)Tj
3.2541 0 Td
(that)Tj
1.7745 0 Td
(uPA)Tj
1.9956 0 Td
(is)Tj
0.8447 0 Td
(a)Tj
0.652 0 Td
(crucial)Tj
2.9139 0 Td
(factor)Tj
2.5455 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.4741 0 Td
(process)Tj
3.1804 0 Td
(of)Tj
1.0148 0 Td
(tumor)Tj
2.7439 0 Td
(progression)Tj
4.9209 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(].)Tj
-36.0337 -1.2983 Td
(uPA)Tj
1.9899 0 Td
(and)Tj
1.7291 0 Td
(PAI-1)Tj
2.6305 0 Td
(have)Tj
2.058 0 Td
(been)Tj
2.1259 0 Td
(investigated)Tj
4.989 0 Td
(as)Tj
1.0148 0 Td
(prognostic)Tj
4.4843 0 Td
(factors)Tj
2.9027 0 Td
(in)Tj
1.0375 0 Td
(early)Tj
2.1486 0 Td
(breast)Tj
2.6136 0 Td
(cancer)Tj
2.8459 0 Td
(in)Tj
1.0375 0 Td
(many)Tj
2.4775 0 Td
(ret-)Tj
-36.0848 -1.3039 Td
(rospective)Tj
4.2632 0 Td
(and)Tj
1.7348 0 Td
(prospective,)Tj
5.006 0 Td
(independent)Tj
5.2781 0 Td
(clinical)Tj
3.0727 0 Td
(trials)Tj
2.1997 0 Td
(ever)Tj
1.8935 0 Td
(since.)Tj
2.4661 0 Td
(The)Tj
1.7858 0 Td
(determination)Tj
5.9528 0 Td
(of)Tj
1.0147 0 Td
(uPA)Tj
-34.6674 -1.2983 Td
(and)Tj
1.7291 0 Td
(PAI-1)Tj
2.6305 0 Td
(concentration)Tj
5.8167 0 Td
(in)Tj
1.0374 0 Td
(tumor)Tj
2.744 0 Td
(tissue)Tj
2.4604 0 Td
(by)Tj
1.1792 0 Td
(enzyme-linked)Tj
6.1625 0 Td
(immunosorbent)Tj
6.7294 0 Td
(assay)Tj
2.262 0 Td
(\(ELISA\))Tj
3.5093 0 Td
(is)Tj
-36.2605 -1.2982 Td
(the)Tj
1.4683 0 Td
(first)Tj
1.8085 0 Td
(prospectively)Tj
5.4821 0 Td
(validated)Tj
3.8325 0 Td
(biomarker)Tj
4.4163 0 Td
(in)Tj
1.0375 0 Td
(early)Tj
2.1486 0 Td
(breast)Tj
2.6192 0 Td
(cancer)Tj
2.8403 0 Td
(with)Tj
2.0013 0 Td
(level)Tj
2.0126 0 Td
(of)Tj
1.0148 0 Td
(evidence)Tj
3.7133 0 Td
(\(LOE\))Tj
-34.3953 -1.3039 Td
(1A,)Tj
1.6043 0 Td
(following)Tj
3.9799 0 Td
(the)Tj
1.4683 0 Td
(systematics)Tj
4.7225 0 Td
(of)Tj
1.0148 0 Td
(Hayes)Tj
2.6589 0 Td
(et)Tj
0.9411 0 Td
(al)Tj
0.9014 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(].)Tj
1.6044 0 Td
(As)Tj
1.2642 0 Td
(part)Tj
1.8369 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(multicenter)Tj
4.8642 0 Td
(Chemo-N0-trial)Tj
-29.3497 -1.2983 Td
(\(n)Tj
1.1055 0 Td
(=)Tj
0.7993 0 Td
(647,)Tj
1.8765 0 Td
(12)Tj
1.1679 0 Td
(centers\),)Tj
3.634 0 Td
(it)Tj
0.788 0 Td
(was)Tj
1.7008 0 Td
(shown)Tj
2.846 0 Td
(that)Tj
1.7801 0 Td
(in)Tj
1.0375 0 Td
(N0)Tj
1.4286 0 Td
(patients)Tj
3.3676 0 Td
(the)Tj
1.4683 0 Td
(uPA/PAI-1)Tj
4.7338 0 Td
(test)Tj
1.5988 0 Td
(can)Tj
1.6271 0 Td
(identify)Tj
3.2938 0 Td
(a)Tj
-34.2536 -1.2983 Td
(group)Tj
2.6078 0 Td
(of)Tj
1.0148 0 Td
(patients)Tj
3.3675 0 Td
(that)Tj
1.7802 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
1.1452 0 Td
(spared)Tj
2.8573 0 Td
(adjuvant)Tj
3.702 0 Td
(CTX)Tj
2.1486 0 Td
([)Tj
0.83 0.64 0.02 0 k
(8)Tj
0 g
(].)Tj
1.5988 0 Td
(Based)Tj
2.5455 0 Td
(on)Tj
1.2755 0 Td
(these)Tj
2.2564 0 Td
(results)Tj
2.8063 0 Td
(and)Tj
1.7291 0 Td
(on)Tj
1.2756 0 Td
(the)Tj
1.474 0 Td
(data)Tj
-35.2117 -1.3039 Td
(from)Tj
2.2053 0 Td
(a)Tj
0.652 0 Td
(comprehensive)Tj
6.2872 0 Td
(meta-analysis)Tj
5.6522 0 Td
(\(n)Tj
1.1112 0 Td
(=)Tj
0.7993 0 Td
(8377\))Tj
2.4605 0 Td
(conducted)Tj
4.4277 0 Td
(by)Tj
1.1849 0 Td
(the)Tj
1.4683 0 Td
(European)Tj
4.1216 0 Td
(Organisation)Tj
5.4651 0 Td
(for)Tj
-35.8353 -1.2983 Td
(Research)Tj
3.804 0 Td
(and)Tj
1.7291 0 Td
(Treatment)Tj
4.4504 0 Td
(of)Tj
1.0148 0 Td
(Cancer)Tj
3.0841 0 Td
(\(EORTC\))Tj
4.1102 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
(],)Tj
1.6044 0 Td
(uPA/PAI-1)Tj
4.7281 0 Td
(has)Tj
1.5421 0 Td
(been)Tj
2.126 0 Td
(recommended)Tj
6.032 0 Td
(as)Tj
1.0148 0 Td
(bio-)Tj
-35.24 -1.2982 Td
(marker)Tj
3.135 0 Td
(for)Tj
1.389 0 Td
(risk)Tj
1.7121 0 Td
(stratification)Tj
5.2838 0 Td
(and)Tj
1.7291 0 Td
(therapeutic)Tj
4.7338 0 Td
(decision)Tj
3.5433 0 Td
(making)Tj
3.2542 0 Td
(in)Tj
1.0374 0 Td
(node-negative)Tj
5.8904 0 Td
(breast)Tj
2.6135 0 Td
(cancer)Tj
-34.3216 -1.2983 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(guidelines)Tj
4.2746 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(American)Tj
4.1953 0 Td
(Society)Tj
3.067 0 Td
(of)Tj
1.0148 0 Td
(Clinical)Tj
3.3165 0 Td
(Oncology)Tj
4.1216 0 Td
(\(ASCO\))Tj
3.4696 0 Td
(since)Tj
2.245 0 Td
(2007)Tj
2.1203 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(of)Tj
-36.663 -1.3039 Td
(the)Tj
1.4683 0 Td
(German)Tj
3.5319 0 Td
(Society)Tj
3.0728 0 Td
(of)Tj
1.0148 0 Td
(Gynecological)Tj
5.879 0 Td
(Oncology)Tj
4.1215 0 Td
(\(AGO\))Tj
3.0444 0 Td
(since)Tj
2.245 0 Td
(2006)Tj
2.1204 0 Td
([)Tj
0.83 0.64 0.02 0 k
(10)Tj
0 g
(])Tj
1.8538 0 Td
([)Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
2.0749 0 Td
(Despite)Tj
3.2485 0 Td
(convinc-)Tj
-33.6753 -1.2983 Td
(ing)Tj
1.5023 0 Td
(data)Tj
1.9105 0 Td
(and)Tj
1.7292 0 Td
(a)Tj
0.6576 0 Td
(commercially)Tj
5.6522 0 Td
(available)Tj
3.6681 0 Td
(ELISA)Tj
2.8289 0 Td
(assay)Tj
2.262 0 Td
(for)Tj
1.389 0 Td
(uPA/PAI-1,)Tj
4.9549 0 Td
(the)Tj
1.4684 0 Td
(proteolytic)Tj
4.5354 0 Td
(factors)Tj
2.9026 0 Td
(are)Tj
-35.4611 -1.2982 Td
(not)Tj
1.5703 0 Td
(generally)Tj
3.8381 0 Td
(used)Tj
2.058 0 Td
(as)Tj
1.0148 0 Td
(biomarkers)Tj
4.7791 0 Td
(for)Tj
1.3833 0 Td
(prognostic)Tj
4.4901 0 Td
(assessment)Tj
4.6091 0 Td
(of)Tj
1.0148 0 Td
(early)Tj
2.1486 0 Td
(breast)Tj
2.6136 0 Td
(cancer)Tj
2.8459 0 Td
(in)Tj
1.0375 0 Td
(clinical)Tj
-33.4032 -1.3039 Td
(practice.)Tj
3.5999 0 Td
(Also)Tj
2.0183 0 Td
(uPA/PAI-1)Tj
4.7338 0 Td
(has)Tj
1.542 0 Td
(never)Tj
2.4435 0 Td
(been)Tj
2.1203 0 Td
(included)Tj
3.7134 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.6519 0 Td
(prognostic)Tj
4.4844 0 Td
(factor)Tj
2.5455 0 Td
(in)Tj
1.0318 0 Td
(the)Tj
1.474 0 Td
(recommenda-)Tj
-31.3736 -1.2983 Td
(tions)Tj
2.1996 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(St.)Tj
1.2188 0 Td
(Gallen)Tj
2.8347 0 Td
(Consensus)Tj
4.524 0 Td
(Conference.)Tj
5.0684 0 Td
(One)Tj
1.9332 0 Td
(reason)Tj
2.8686 0 Td
(for)Tj
1.3833 0 Td
(this)Tj
1.6781 0 Td
(may)Tj
1.9276 0 Td
(be)Tj
1.1508 0 Td
(that)Tj
1.7745 0 Td
(uPA/PAI-1)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I0 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 239.6976 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Prospective)Tj
5.3575 0 Td
(comparison)Tj
5.3008 0 Td
(of)Tj
1.0417 0 Td
(different)Tj
3.7702 0 Td
(biomarke)Tj
4.0394 0 Td
(rs)Tj
1.0417 0 Td
(EndoPred)Tj
4.3725 0 Td
(ict)Tj
1.1976 0 Td
(and)Tj
1.8567 0 Td
(uPA/PAI-1)Tj
4.8331 0 Td
(in)Tj
0.978 0 Td
(early)Tj
2.3386 0 Td
(breast)Tj
2.9551 0 Td
(cancer)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.01839)Tj
4.089 0 Td
(17)Tj
0 g
2.0906 0 Td
(September)Tj
5.0386 0 Td
(6,)Tj
1.0418 0 Td
(2017)Tj
32.8254 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
0.496 0 Td
(14)Tj
/F7 1 Tf
-0.025 Tc
-66.402 84.0904 Td
(Funding:)Tj
/F8 1 Tf
3.5716 0 Td
(The)Tj
1.5874 0 Td
(authors)Tj
3.0473 0 Td
(received)Tj
3.3024 0 Td
(no)Tj
1.1622 0 Td
(specific)Tj
3.026 0 Td
(funding)Tj
-15.6969 -1.3748 Td
(for)Tj
1.2543 0 Td
(this)Tj
1.5661 0 Td
(work.)Tj
/F7 1 Tf
-2.8204 -2.126 Td
(Competing)Tj
4.3795 0 Td
(interests)Tj
3.3307 0 Td
(:)Tj
/F8 1 Tf
0.4819 0 Td
(JE,)Tj
1.3323 0 Td
(EK,)Tj
1.4457 0 Td
(AH,)Tj
1.5591 0 Td
(KG,)Tj
1.559 0 Td
(SP,)Tj
1.4883 0 Td
(LW,)Tj
1.7291 0 Td
(KS,)Tj
-17.3056 -1.3749 Td
(HH)Tj
1.396 0 Td
(declared)Tj
3.352 0 Td
(no)Tj
1.1693 0 Td
(competing)Tj
4.1599 0 Td
(interes)Tj
2.4874 0 Td
(ts.)Tj
1.1268 0 Td
(CP)Tj
1.2685 0 Td
(is)Tj
0.8362 0 Td
(a)Tj
0.6378 0 Td
(former)Tj
-16.4339 -1.3748 Td
(employee)Tj
3.7984 0 Td
(of)Tj
0.9496 0 Td
(Sividon)Tj
2.9764 0 Td
(Diagnost)Tj
3.2953 0 Td
(ics,)Tj
1.4811 0 Td
(the)Tj
1.3678 0 Td
(manufacture)Tj
4.6772 0 Td
(r)Tj
-18.5458 -1.3748 Td
(of)Tj
0.9496 0 Td
(the)Tj
1.3677 0 Td
(EndoPredi)Tj
3.8126 0 Td
(ct)Tj
0.9 0 Td
(test,)Tj
1.8 0 Td
(and)Tj
1.5875 0 Td
(received)Tj
3.3023 0 Td
(a)Tj
0.6378 0 Td
(salary)Tj
2.4095 0 Td
(as)Tj
-16.767 -1.3748 Td
(well)Tj
1.6653 0 Td
(as)Tj
1.063 0 Td
(a)Tj
0.6449 0 Td
(bonus)Tj
2.5299 0 Td
(from)Tj
2.0127 0 Td
(the)Tj
1.3677 0 Td
(sales)Tj
2.1047 0 Td
(of)Tj
0.9426 0 Td
(the)Tj
1.3748 0 Td
(EndoPredi)Tj
3.8126 0 Td
(ct)Tj
-17.5182 -1.3748 Td
(test.)Tj
1.8 0 Td
(CP)Tj
1.2685 0 Td
(is)Tj
0.8362 0 Td
(an)Tj
1.1126 0 Td
(inventor)Tj
3.2386 0 Td
(on)Tj
1.1693 0 Td
(patents)Tj
2.941 0 Td
(relating)Tj
2.9551 0 Td
(to)Tj
-15.3213 -1.3748 Td
(EndoPredi)Tj
3.8126 0 Td
(ct)Tj
0.9 0 Td
(but)Tj
1.4173 0 Td
(has)Tj
1.5378 0 Td
(no)Tj
1.1693 0 Td
(financial)Tj
3.267 0 Td
(interest)Tj
2.9693 0 Td
(of)Tj
0.9496 0 Td
(such)Tj
-16.0229 -1.3748 Td
(patents.)Tj
3.1677 0 Td
(MK)Tj
1.4953 0 Td
(received)Tj
3.3024 0 Td
(honorarium)Tj
4.5709 0 Td
(for)Tj
1.2543 0 Td
(lectures)Tj
-13.7906 -1.3749 Td
(about)Tj
2.3173 0 Td
(gene)Tj
2.0126 0 Td
(expressi)Tj
3.0756 0 Td
(on)Tj
1.1693 0 Td
(tests)Tj
1.9985 0 Td
(from)Tj
2.0055 0 Td
(Sividon)Tj
-12.5788 -1.3748 Td
(Diagnostic)Tj
3.9118 0 Td
(s.)Tj
0.8646 0 Td
(This)Tj
1.7858 0 Td
(does)Tj
2.0055 0 Td
(not)Tj
1.4245 0 Td
(alter)Tj
1.8212 0 Td
(our)Tj
1.4741 0 Td
(adherenc)Tj
3.4086 0 Td
(e)Tj
0.6449 0 Td
(to)Tj
-17.341 -1.3748 Td
(PLOS)Tj
2.3315 0 Td
(ONE)Tj
1.8708 0 Td
(policies)Tj
3.0119 0 Td
(on)Tj
1.1622 0 Td
(sharing)Tj
2.9835 0 Td
(data)Tj
1.7929 0 Td
(and)Tj
ET
endstream
endobj
28 0 obj
<>stream
endstream
endobj
29 0 obj
<>stream
endstream
endobj
30 0 obj
<>stream
endstream
endobj
31 0 obj
<>stream
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
BT
14.7402 66.8414 Td
(materials.)Tj
ET
Q
endstream
endobj
40 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 11 0 R/Annots 42 0 R/Contents 43 0 R/TrimBox[0 0 612 792]>>
endobj
41 0 obj
<>
endobj
44 0 obj
<>
endobj
45 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /PI_chars_3 def
/FontType 1 def
/FontBBox {-11 -345 1373 718} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (PI_chars_3) readonly def
/BaseFontName (PI_chars_3) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 58 /colon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤/{zM4aܪ
Q:д'B-r^ܦ6y?rRnu S\U{Oλrs(Βƚ
#d29%s'ƈT1F8&\0Xd&&Zug'VPd]:>u=Q,?#(CV4'..|ӱ5 h
sȀg)fɘ`UXK^>] q\l#5pE"JO}rquáQBr/E7
QW5\GSlu{7ZH(PSf/O;̟w{ɴ}-K hA8!b!U>`#u?Vlnǝ19V+mg'QmA}S Y$í8n uJ ڒx3>[x0Z]
ͩw4M&1+pkC,sr"%q&OjbH{:5$65*S`cr;%s4Oӆe>T+6~pBOD!$c]"~r#nh6$38i˞[~Z}}rHmte9(1½=j{<\ ;? RA?c{Rf1'VԞ_-Lwo]`.l|zjf"![G1BYro˓9[-+z g!}RN+pX!M~HcFh@g%J6B)6!Lq>TX\ݪGF
PiQݓX~Fs;Ölo4/(C?+,ɖxۼ:xU^)
fd,`*>-:}=q$:\Xzcw1Nf(
ZkEeJXfэi@zXc\{a5qKg\5ݩv\Qe%1>OY̗$Y#P[)."^+{"bP]Bt&zeN6
іijDE% 0;̅
~~lfB>u'i4znym%tfԟ^נBTDS6-ghiWk/(r!!˶fc>趕%U